← Open Payments lookup

CLARO MARK MABAZZA: Open Payments

NPI 1326617358 · BELLFLOWER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,211 in 45 payments from 8 companies in 2025. Trend: 2023 $379 · 2024 $498 · 2025 $1,211

Food & beverage: $1,211
CompanyPaymentsAmount
ABBVIE INC.18$366
Neurocrine BioSciences, Inc.8$255
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$159
Janssen Pharmaceuticals, Inc1$141
Otsuka America Pharmaceutical, Inc.1$104
Bausch Health US, LLC5$103
Vanda Pharmaceuticals Inc.2$42
Alkermes, Inc.2$42

Products named: VRAYLAR, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, APLENZIN, FANAPT, ARISTADA.

Industry payments across CA — which companies pay providers there.